Vaccine Therapy in Chronic Hepatitis B Carriers: A Randomised Double-Blind Controlled Trial

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 8

Abstract

ABSTRACT Introduction: Chronic carriers of Hepatitis B Virus (HBV) are persistent sources of the virus and may transmit HBV to healthy individuals. Aim: This study was conducted to assess therapeutic effects of HBV vaccine on Chronic HBV Carriers (CHC). Methods and Materials: This clinical trial was conducted on CHCs aged 20-65 years, randomly allocated into four groups. Group 1 (control) did not receive vaccine. Group 2, 3 and 4 (vaccine groups) received different doses of HBV vaccine. HBV viral load (IU/mL) was assessed at baseline and two months after the last dose of HBV vaccine. Reduction or elimination of HBV viral load was considered as positive response. Absolute Response Rates (ARR) was calculated for each group. Subgroup analysis was done on subjects with baseline viral load of <100,000 and negative HBeAb. Relative Response Rates (RRR) was defined as ARR in vaccine group divided by that of control. RRRs were calculated for total participants (overall RRR) and the above-mentioned subgroup of subjects (subgroup RRR). Results: In total, 97 CHCs were recruited. No adverse reaction was reported. There was no significant difference in ARRs between study groups (p-value=0.09). An overall RRR of 0.78 and a subgroup RRR of 1.18 has been reported. A 50% increase was found in the RRR in subgroups of subjects with baseline viral load of <100,000 and negative HBeAb compared to the overall RRR. Conclusion: It may be worth future studies to assess the therapeutic effects of HBV vaccine.

Authors and Affiliations

Behnaz Khodabakhshi, Gholamreza Roshandel, Abdollah Abbasi, Aida Hashemifard, Sima Besharat, Fatemeh Ghasemi Kebria, Abdolvahab Moradi

Keywords

Related Articles

Brain Derived Neurotrophic Factor as a Treatment Modality: The Future of Clinical Neurosciences

ABSTRACT Brain Derived Neurotrophic Factor (BDNF) is one of the Neurotrophic factors responsible for the survival, growth, differentiation and maturation of neurons. BDNF has been reported to have multiple physiological...

Anatomical and Morphometric Study of the Pes Anserine Tendons in the Knee

ABSTRACT Introduction: The anatomical and topographical study of insertion of the pes anserinus is of fundamental importance for obtaining autogenous grafts in knee ligament reconstruction. Aim: To evaluate the topograph...

Large Isolated Major Aortopulmonary Collateral Artery Causing Severe Pulmonary Hypertension in an Infant: A Rare and Challenging Diagnosis

Major Aortopulmonary Collateral Artery (MAPCA) as an isolated congenital anomaly, without evidence of any structural heart disease, is a very rare observation. Previously published reports indicate that symptomatic infan...

Motor Control Training in Chronic Low Back Pain

ABSTRACT Introduction: Chronic Low Back Pain (CLBP) is the most disabling musculoskeletal disorder with altered functioning of the lumbar core muscles. Movement impairment and control impairment syndromes are present in...

Assessing the Utility of Outlet Filters in the Ventilators of ICU Patients

ABSTRACT Introduction: Intensive Care Units (ICU) host a large percentage of all nosocomial infections in any hospital. The air quality in such an environment plays a pivotal role in the dissemination of such infections....

Download PDF file
  • EP ID EP523762
  • DOI 10.7860/JCDR/2018/33890.11899
  • Views 63
  • Downloads 0

How To Cite

Behnaz Khodabakhshi, Gholamreza Roshandel, Abdollah Abbasi, Aida Hashemifard, Sima Besharat, Fatemeh Ghasemi Kebria, Abdolvahab Moradi (2018). Vaccine Therapy in Chronic Hepatitis B Carriers: A Randomised Double-Blind Controlled Trial. Journal of Clinical and Diagnostic Research, 12(8), 18-20. https://europub.co.uk/articles/-A-523762